Yaning Xu
Founder & Managing Director
Yaning Xu: Visionary Leader and Innovator in Biopharmaceutical Technology
View All
With a prolific entrepreneurial journey spanning four decades and over 50 industries, Yaning Xu has left a significant mark on each sector he has ventured into. His career in auto insurance and car service is marked by over 20 years of dedicated service, where he established a profound legacy. His groundbreaking venture, the Annual Insurance Supermarket, stands as a pillar in China's car insurance agency industry, commanding an impressive annual premium volume of over 15 billion RMB.
Beyond his achievements in auto insurance, Yaning has founded more than ten companies within the car service sector, each one a testament to his commitment to enhancing industry standards and customer satisfaction. His ventures are distinguished by innovative service solutions and robust customer support systems, setting new benchmarks for quality and reliability in the market.
Transitioning from his established career in auto services, Yaning embarked on a new challenge driven by his enduring passion for science and innovation. His deep interest in the biological sector led him to the forefront of biopharmaceutical technology. At Natrualbio, Yaning is pioneering the implement of advanced biotechnologies to improve health outcomes. The company, built on the foundation of Dr. Yu Zhong’s α-amylase inhibitor technology, promises significant advancements in treatment options for various ailments.
Yaning Xu's motivation for founding Natrualbio stems from a deep-seated belief in the transformative potential of biotechnology. He is particularly inspired by the sector's robust projected growth over the next 50 years, foreseeing biotech as a key driver of advancements in health and medicine. His commitment is to leverage this growth to develop treatments that offer safer, more effective alternatives to traditional medications, significantly enhancing patient care and well-being.
Looking ahead, Yaning Xu is excited about the next two decades, which he believes will be transformative for the health sector. New treatments and innovative health care models are expected to emerge, dramatically increasing human longevity and improving the quality of life for millions. As a leader in the biopharmaceutical field, Yaning is dedicated to being at the forefront of these developments, pushing the boundaries of what is possible in medical science.
Yaning Xu is not just a business mogul; he is a visionary who continuously seeks to merge technological innovation with practical applications, aiming to make a lasting impact on the industries he touches and the communities he serves. His leadership at Natrualbio is poised to drive breakthroughs in biopharmaceuticals, offering new hope and better health solutions to millions worldwide.
Beyond his achievements in auto insurance, Yaning has founded more than ten companies within the car service sector, each one a testament to his commitment to enhancing industry standards and customer satisfaction. His ventures are distinguished by innovative service solutions and robust customer support systems, setting new benchmarks for quality and reliability in the market.
Transitioning from his established career in auto services, Yaning embarked on a new challenge driven by his enduring passion for science and innovation. His deep interest in the biological sector led him to the forefront of biopharmaceutical technology. At Natrualbio, Yaning is pioneering the implement of advanced biotechnologies to improve health outcomes. The company, built on the foundation of Dr. Yu Zhong’s α-amylase inhibitor technology, promises significant advancements in treatment options for various ailments.
Yaning Xu's motivation for founding Natrualbio stems from a deep-seated belief in the transformative potential of biotechnology. He is particularly inspired by the sector's robust projected growth over the next 50 years, foreseeing biotech as a key driver of advancements in health and medicine. His commitment is to leverage this growth to develop treatments that offer safer, more effective alternatives to traditional medications, significantly enhancing patient care and well-being.
Looking ahead, Yaning Xu is excited about the next two decades, which he believes will be transformative for the health sector. New treatments and innovative health care models are expected to emerge, dramatically increasing human longevity and improving the quality of life for millions. As a leader in the biopharmaceutical field, Yaning is dedicated to being at the forefront of these developments, pushing the boundaries of what is possible in medical science.
Yaning Xu is not just a business mogul; he is a visionary who continuously seeks to merge technological innovation with practical applications, aiming to make a lasting impact on the industries he touches and the communities he serves. His leadership at Natrualbio is poised to drive breakthroughs in biopharmaceuticals, offering new hope and better health solutions to millions worldwide.
Yifei Xu
IP Strategy & Research Manager
Yifei Xu: Intellectual Property Strategy as a Catalyst for Innovation in R&D-Based Technology Companies
View All
Yifei Xu brings a wealth of expertise to NaturalBiotech. He has over eight years of experience dedicated to intellectual property (IP) and three years in management roles, making him a pivotal figure in the company's growth trajectory. Yifei’s career began in a rigorous patent agency environment, where he specialized in patent prosecution and defence across the biopharmaceutical sector. This foundational role honed his skills and shaped his understanding of the critical balance between innovation and IP protection.
His journey as a Patent Specialist involved intricate work with cutting-edge biotechnologies, equipping him with a unique skill set, including setting up commercial operation plans centred on robust IP strategies for novel biotech products. These early experiences exposed him to the challenges many technology companies face—particularly the prohibitive costs of IP protection at initial stages, which often impede the commercial viability and broader application of breakthrough technologies.
Compelled by the need to address these industry-wide challenges, Yifei transitioned from the traditional patent firm setting to a more dynamic role at NaturalBiotech. Since joining the company in 2019 as an IP Strategic Technology Officer, he has revolutionized the company's approaches to IP strategy, intertwining it seamlessly with research and development to foster innovation while safeguarding inventions.
Yifei's approach at NaturalBiotech has been transformative. By streamlining IP processes and introducing cost-effective strategies, he has not only reduced expenses but also accelerated the path from laboratory innovations to market-ready products. His strategic foresight has been instrumental in extending the company’s research endeavours beyond α-amylase blockers to a diverse portfolio that now includes diabetes intervention products, advanced weight loss solutions, and groundbreaking food additives.
Under Yifei's leadership, NaturalBiotech has successfully commercialized other essential technologies such as protein sequencing and spatial transcriptomic sequencing. These technologies are crucial for the development of new therapeutic agents and have broad implications for the future of personalized medicine and biotechnological research.
Yifei's belief in strong IP protection as a driver of rapid technological change is unwavering. He envisions a future where advanced biotechnologies, underpinned by solid IP frameworks, revolutionize our approach to health and wellness. His strategic initiatives continue to enhance NaturalBiotech’s standing as a leader in the biopharmaceutical industry, ensuring that the company not only leads in innovation but also in the effective commercialization and application of these innovations.
Yifei Xu’s leadership exemplifies how strategic IP management is integral to fostering sustainable innovation and maintaining competitive advantage in the fast-evolving biotech landscape.
His journey as a Patent Specialist involved intricate work with cutting-edge biotechnologies, equipping him with a unique skill set, including setting up commercial operation plans centred on robust IP strategies for novel biotech products. These early experiences exposed him to the challenges many technology companies face—particularly the prohibitive costs of IP protection at initial stages, which often impede the commercial viability and broader application of breakthrough technologies.
Compelled by the need to address these industry-wide challenges, Yifei transitioned from the traditional patent firm setting to a more dynamic role at NaturalBiotech. Since joining the company in 2019 as an IP Strategic Technology Officer, he has revolutionized the company's approaches to IP strategy, intertwining it seamlessly with research and development to foster innovation while safeguarding inventions.
Yifei's approach at NaturalBiotech has been transformative. By streamlining IP processes and introducing cost-effective strategies, he has not only reduced expenses but also accelerated the path from laboratory innovations to market-ready products. His strategic foresight has been instrumental in extending the company’s research endeavours beyond α-amylase blockers to a diverse portfolio that now includes diabetes intervention products, advanced weight loss solutions, and groundbreaking food additives.
Under Yifei's leadership, NaturalBiotech has successfully commercialized other essential technologies such as protein sequencing and spatial transcriptomic sequencing. These technologies are crucial for the development of new therapeutic agents and have broad implications for the future of personalized medicine and biotechnological research.
Yifei's belief in strong IP protection as a driver of rapid technological change is unwavering. He envisions a future where advanced biotechnologies, underpinned by solid IP frameworks, revolutionize our approach to health and wellness. His strategic initiatives continue to enhance NaturalBiotech’s standing as a leader in the biopharmaceutical industry, ensuring that the company not only leads in innovation but also in the effective commercialization and application of these innovations.
Yifei Xu’s leadership exemplifies how strategic IP management is integral to fostering sustainable innovation and maintaining competitive advantage in the fast-evolving biotech landscape.
Ellie Vaisman
Marketing Manager
Ellie: Dynamic Leader in Entrepreneurial Biotechnology Ventures
View All
Ellie is a vibrant force at NaturalBiotech, where his entrepreneurial spirit and robust management skills play a pivotal role in the startup and day-to-day scaling of the company’s enterprises. Known for his boundless energy and unwavering integrity, Ellie embodies the essence of old-school grit and vigour, consistently delivering on his promises and driving key projects to success.
At NaturalBiotech, Ellie spearheads the introduction and promotion of high-value biotech products in the Australian market and public health sectors. He has established a formidable reputation for managing highly critical goods procurement, particularly during times of crisis. His leadership was instrumental in the successful distribution of calorie-controlled potato chip additives based on α-amylase blockers, as well as exclusive products from NaturalBiotech’s Bio-synthesis Platform. These initiatives are vital in positioning the company at the forefront of biotechnological solutions tailored to enhance public health and well-being.
On a daily basis, Ellie and his dedicated team focus on marketing and promoting essential biotech goods. Their efforts are central to supporting the health and improving the lives of the Australian populace. Under his guidance, the team not only meets but often exceeds, the dynamic needs of the market through strategic innovation and keen market insights.
Outside of his professional life, Ellie is deeply committed to his young family, drawing joy and inspiration from his personal life. He is a connoisseur of food and coffee, constantly seeking new culinary experiences and the perfect brew. An avid life-hacker, Ellie also explores wellness trends aligning with his lifestyle, promoting a balanced health and personal development approach.
Ellie’s dynamic approach to leadership, combined with his passion for health and wellness, makes him a quintessential part of NaturalBiotech’s success and future endeavours. His ability to navigate complex challenges and his commitment to innovation continue to enhance the company's impact on the biotechnology industry and community.
At NaturalBiotech, Ellie spearheads the introduction and promotion of high-value biotech products in the Australian market and public health sectors. He has established a formidable reputation for managing highly critical goods procurement, particularly during times of crisis. His leadership was instrumental in the successful distribution of calorie-controlled potato chip additives based on α-amylase blockers, as well as exclusive products from NaturalBiotech’s Bio-synthesis Platform. These initiatives are vital in positioning the company at the forefront of biotechnological solutions tailored to enhance public health and well-being.
On a daily basis, Ellie and his dedicated team focus on marketing and promoting essential biotech goods. Their efforts are central to supporting the health and improving the lives of the Australian populace. Under his guidance, the team not only meets but often exceeds, the dynamic needs of the market through strategic innovation and keen market insights.
Outside of his professional life, Ellie is deeply committed to his young family, drawing joy and inspiration from his personal life. He is a connoisseur of food and coffee, constantly seeking new culinary experiences and the perfect brew. An avid life-hacker, Ellie also explores wellness trends aligning with his lifestyle, promoting a balanced health and personal development approach.
Ellie’s dynamic approach to leadership, combined with his passion for health and wellness, makes him a quintessential part of NaturalBiotech’s success and future endeavours. His ability to navigate complex challenges and his commitment to innovation continue to enhance the company's impact on the biotechnology industry and community.
Rongkuo Li
Biological Technician
View All
Rongkuo Li is a dedicated young professional who recently graduated from The University of Melbourne. As a Biological Technician, Rongkuo is actively engaged in the innovative landscape of research and development within the biotechnology sector, bringing enthusiasm and a rigorous scientific approach to his role.
During his academic journey, Rongkuo developed a strong passion for the practical application of biological science, which led him to focus on biotechnological methods and techniques. His education provided him with a solid grounding in scientific concepts and laboratory practices, which he adeptly applies to his current position in a dynamic R&D environment.
Since joining his organization, Rongkuo has been instrumental in supporting various phases of the research process. His responsibilities include setting up experiments, gathering and analyzing data, and contributing to the development of reports and presentations that aid in advancing biotechnological innovations aimed at improving public health and environmental practices.
Committed to professional growth, Rongkuo regularly participates in workshops and seminars to stay updated with the latest advancements in his field. His dedication to his work is evident through his meticulous attention to detail and his collaborative spirit, working seamlessly with teams across multiple disciplines.
Beyond his professional pursuits, Rongkuo is a passionate advocate for the conservation of South Australia's unique natural environment. He takes an active role in local environmental initiatives and enjoys exploring the region’s diverse ecosystems. His interests also include sampling the local cuisine and engaging in outdoor activities that showcase the beauty of his home state.
Looking ahead, Rongkuo aims to deepen his expertise in a specialized area of biotechnology and seeks to take on greater responsibilities in project management. He is driven to make meaningful contributions to the scientific community and to impact positively on the world around him.
During his academic journey, Rongkuo developed a strong passion for the practical application of biological science, which led him to focus on biotechnological methods and techniques. His education provided him with a solid grounding in scientific concepts and laboratory practices, which he adeptly applies to his current position in a dynamic R&D environment.
Since joining his organization, Rongkuo has been instrumental in supporting various phases of the research process. His responsibilities include setting up experiments, gathering and analyzing data, and contributing to the development of reports and presentations that aid in advancing biotechnological innovations aimed at improving public health and environmental practices.
Committed to professional growth, Rongkuo regularly participates in workshops and seminars to stay updated with the latest advancements in his field. His dedication to his work is evident through his meticulous attention to detail and his collaborative spirit, working seamlessly with teams across multiple disciplines.
Beyond his professional pursuits, Rongkuo is a passionate advocate for the conservation of South Australia's unique natural environment. He takes an active role in local environmental initiatives and enjoys exploring the region’s diverse ecosystems. His interests also include sampling the local cuisine and engaging in outdoor activities that showcase the beauty of his home state.
Looking ahead, Rongkuo aims to deepen his expertise in a specialized area of biotechnology and seeks to take on greater responsibilities in project management. He is driven to make meaningful contributions to the scientific community and to impact positively on the world around him.
Dr.Yu Zhong
Associate Researcher
View All
Dr. Yu Zhong is a distinguished scientist and technology development engineer with a profound specialty in microbiology and biosciences. He holds a Master of Science in Enterprise in Biosciences and a degree in Microbiology, both from the University of Sunderland, UK. His academic background has provided a robust foundation for his innovative contributions to biotechnology.
As the lead designer of alpha-amylase blockers and the visionary founder of NaturalBiotech’s calorie control orientation technology, Dr. Zhong has revolutionized approaches to managing dietary health and obesity with groundbreaking scientific rigour. His dedication to the field of amylase blockers has positioned him as a leading figure in the biotechnological community, particularly in the area of metabolic health innovations.
Dr. Zhong’s career is marked by a commitment to bridging the gap between complex scientific research and practical health solutions. His work at NaturalBiotech has not only pioneered novel biotechnologies but has also successfully guided these innovations from the laboratory to the marketplace. In collaboration with NaturalBiotech and various institutions in South Australia, his research has been optimized and commercialized, leading to enhanced dietary products that benefit a wide range of consumers.
The integration of Dr. Zhong’s research with commercial strategies exemplifies his dual expertise as a scientist and an entrepreneur. His efforts have significantly advanced the field of biotechnology, making substantial impacts on public health through the development of accessible, effective, and scientifically validated health products.
Dr. Zhong’s professional journey is characterized by a relentless pursuit of excellence and innovation. His work continues to influence the biotechnological landscape, contributing to healthier lifestyles through scientific discovery and application.
As the lead designer of alpha-amylase blockers and the visionary founder of NaturalBiotech’s calorie control orientation technology, Dr. Zhong has revolutionized approaches to managing dietary health and obesity with groundbreaking scientific rigour. His dedication to the field of amylase blockers has positioned him as a leading figure in the biotechnological community, particularly in the area of metabolic health innovations.
Dr. Zhong’s career is marked by a commitment to bridging the gap between complex scientific research and practical health solutions. His work at NaturalBiotech has not only pioneered novel biotechnologies but has also successfully guided these innovations from the laboratory to the marketplace. In collaboration with NaturalBiotech and various institutions in South Australia, his research has been optimized and commercialized, leading to enhanced dietary products that benefit a wide range of consumers.
The integration of Dr. Zhong’s research with commercial strategies exemplifies his dual expertise as a scientist and an entrepreneur. His efforts have significantly advanced the field of biotechnology, making substantial impacts on public health through the development of accessible, effective, and scientifically validated health products.
Dr. Zhong’s professional journey is characterized by a relentless pursuit of excellence and innovation. His work continues to influence the biotechnological landscape, contributing to healthier lifestyles through scientific discovery and application.
Dr.Luyi Tian
Associate Researcher
View All
Dr. Luyi Tian is a distinguished geneticist whose groundbreaking work spans several top research institutions, including the Broad Research Center at Harvard University and MIT. Known for his rigorous research and deep expertise, Dr. Tian has authored numerous high-quality articles in premier life science journals such as Cell and Nature, highlighting his contributions to the field of genetics and his role in advancing commercial research outcomes.
Before his current appointments, Dr. Tian honed his skills and knowledge at CSL (Australia) and the Walter and Eliza Hall Institute of The University of Melbourne, where he made significant advancements as a genetic scientist. His experience in these roles laid the groundwork for his innovative approaches in genetic research and therapy development.
At NaturalBiotech, Dr. Tian has been instrumental in developing and refining key technologies that are pivotal to the company’s success. His expertise in protein synthesis, protein sequencing, and spatial genomics sequencing has propelled the commercial viability of amylase blockers, which are central to NaturalBiotech’s product line. These technologies are not just enhancing the company's product offerings but are also setting new standards in the biotechnology industry.
Dr. Tian’s work at NaturalBiotech exemplifies his commitment to translating complex genetic research into practical applications that have tangible benefits in health and medicine. His efforts are crucial in developing new biotechnological products that promise to improve health outcomes and enhance the quality of life for people around the globe.
Before his current appointments, Dr. Tian honed his skills and knowledge at CSL (Australia) and the Walter and Eliza Hall Institute of The University of Melbourne, where he made significant advancements as a genetic scientist. His experience in these roles laid the groundwork for his innovative approaches in genetic research and therapy development.
At NaturalBiotech, Dr. Tian has been instrumental in developing and refining key technologies that are pivotal to the company’s success. His expertise in protein synthesis, protein sequencing, and spatial genomics sequencing has propelled the commercial viability of amylase blockers, which are central to NaturalBiotech’s product line. These technologies are not just enhancing the company's product offerings but are also setting new standards in the biotechnology industry.
Dr. Tian’s work at NaturalBiotech exemplifies his commitment to translating complex genetic research into practical applications that have tangible benefits in health and medicine. His efforts are crucial in developing new biotechnological products that promise to improve health outcomes and enhance the quality of life for people around the globe.
Richard Xiao
Project Development Advisor
View All
Wei Xiao is a seasoned investment manager with extensive experience across diverse sectors, including real estate and bio-health industries in China and Australia. With a keen focus on investment management and strategic project planning, Mr. Xiao has consistently demonstrated his ability to navigate complex market dynamics and deliver robust investment returns.
Throughout his career, Mr. Xiao has cultivated a rich portfolio of investments, showcasing his adeptness not only in identifying lucrative opportunities but also in executing strategies that enhance asset value and ensure long-term sustainability. His expertise extends beyond mere financial management to encompass a comprehensive understanding of the regulatory and economic environments of both China and Australia, allowing him to optimize investment structures for maximum efficiency and compliance.
In the realm of real estate, Mr. Xiao has been instrumental in developing and managing several high-profile projects. His strategic foresight has led to the revitalization of properties and the creation of thriving communities, thereby significantly increasing property values and investor satisfaction. His approach always involves a thorough analysis of market trends, demographic data, and financial forecasting, ensuring that all real estate investments are well-positioned for future growth and success.
In the bio-health sector, Mr. Xiao has leveraged his investment acumen to support and grow innovative enterprises that are at the forefront of medical technology and services. His contributions have been pivotal in advancing new technologies that address critical health issues, thus enhancing public health outcomes and generating substantial economic value.
As an advisor, Mr. Xiao excels in project planning, bringing a structured and detailed approach to the development and execution of investment strategies. His ability to lead multidisciplinary teams ensures that all aspects of a project, from inception through to completion, are aligned with strategic business objectives.
Throughout his career, Mr. Xiao has cultivated a rich portfolio of investments, showcasing his adeptness not only in identifying lucrative opportunities but also in executing strategies that enhance asset value and ensure long-term sustainability. His expertise extends beyond mere financial management to encompass a comprehensive understanding of the regulatory and economic environments of both China and Australia, allowing him to optimize investment structures for maximum efficiency and compliance.
In the realm of real estate, Mr. Xiao has been instrumental in developing and managing several high-profile projects. His strategic foresight has led to the revitalization of properties and the creation of thriving communities, thereby significantly increasing property values and investor satisfaction. His approach always involves a thorough analysis of market trends, demographic data, and financial forecasting, ensuring that all real estate investments are well-positioned for future growth and success.
In the bio-health sector, Mr. Xiao has leveraged his investment acumen to support and grow innovative enterprises that are at the forefront of medical technology and services. His contributions have been pivotal in advancing new technologies that address critical health issues, thus enhancing public health outcomes and generating substantial economic value.
As an advisor, Mr. Xiao excels in project planning, bringing a structured and detailed approach to the development and execution of investment strategies. His ability to lead multidisciplinary teams ensures that all aspects of a project, from inception through to completion, are aligned with strategic business objectives.